CD8A and neoplasm: During tumour development, dendritic cells (DCs) present MHC-I molecules of tumour antigens to CD8+ T cells, activating them into cytotoxic T lymphocytes (CTLs) (18), whereas Th cells further promote the proliferation and activation of CD8+ T cells (19).